Nektar(NKTR) - 2023 Q3 - Earnings Call Transcript

Nektar Therapeutics (NASDAQ:NKTR) Q3 2023 Earnings Conference Call November 7, 2023 5:00 PM ET Company Participants Vivian Wu - Director, IR and Corporate Affairs Howard Robin - President and CEO Jonathan Zalevsky - Chief, Research and Development Mary Tagliaferri - Chief Medical Officer Jennifer Ruddock - Chief Business Officer Conference Call Participants Jay Olson - Oppenheimer Charles Ferranti - Goldman Sachs Operator Good day and thank you for standing by. Welcome to the Nektar Therapeutics Third Quart ...